BACKGROUND Hepatitis B virus(HBV)is a major cause of hepatocellular carcinoma(HCC).HBV DNA can get integrated into the hepatocyte genome to promote carcinogenesis.However,the precise mechanism by which the integrated ...BACKGROUND Hepatitis B virus(HBV)is a major cause of hepatocellular carcinoma(HCC).HBV DNA can get integrated into the hepatocyte genome to promote carcinogenesis.However,the precise mechanism by which the integrated HBV genome promotes HCC has not been elucidated.AIM To analyze the features of HBV integration in HCC using a new reference database and integration detection method.METHODS Published data,consisting of 426 Liver tumor samples and 426 paired adjacent non-tumor samples,were re-analyzed to identify the integration sites.Genome Reference Consortium Human Build 38(GRCh38)and Telomere-to-Telomere Consortium CHM13(T2T-CHM13(v2.0))were used as the human reference genomes.In contrast,human genome 19(hg19)was used in the original study.In addition,GRIDSS VIRUSBreakend was used to detect HBV integration sites,whereas high-throughput viral integration detection(HIVID)was applied in the original study(HIVID-hg19).RESULTS A total of 5361 integration sites were detected using T2T-CHM13.In the tumor samples,integration hotspots in the cancer driver genes,such as TERT and KMT2B,were consistent with those in the original study.GRIDSS VIRUSBreakend detected integrations in more samples than by HIVID-hg19.Enrichment of integration was observed at chromosome 11q13.3,including the CCND1 pro-moter,in tumor samples.Recurrent integration sites were observed in mitochondrial genes.CONCLUSION GRIDSS VIRUSBreakend using T2T-CHM13 is accurate and sensitive in detecting HBV integration.Re-analysis provides new insights into the regions of HBV integration and their potential roles in HCC development.展开更多
目的:评价补阳还五汤联合手术治疗腰椎管狭窄症的有效性。方法:应用PubMed、Embase、Web of Science、万方(WanFang)、中国知网(CNKI)、中国生物医学文献库(CBM)等数据库检索有关补阳还五汤结合手术治疗腰椎管狭窄症的文献,使用Cochran...目的:评价补阳还五汤联合手术治疗腰椎管狭窄症的有效性。方法:应用PubMed、Embase、Web of Science、万方(WanFang)、中国知网(CNKI)、中国生物医学文献库(CBM)等数据库检索有关补阳还五汤结合手术治疗腰椎管狭窄症的文献,使用Cochrane偏倚风险评估标准对文献进行评价,应用RevMan软件进行数据分析。结果:共纳入文献10篇,涉及腰椎管狭窄症患者728例,Meta分析结果显示补阳还五汤结合手术治疗腰椎管狭窄症优于单纯手术治疗,其中有效率[OR=3.26,95%CI(1.66,6.40),P<0.05]、视觉模拟评分(VAS)[WMD=-0.61,95%CI(-1.11,-0.11),P=0.02]、Owsestry功能障碍指数(ODI)[WMD=-3.09,95%CI(-4.49,-1.70),P<0.05]、日本骨科学会腰椎疗效评分(JOA)[WMD=2.00,95%CI(0.57,3.43),P<0.05]、C反应蛋白水平[WMD=-2.24,95%CI(-2.69,-1.80),P<0.05]。结论:补阳还五汤结合手术治疗腰椎管狭窄症的疗效优于单纯手术治疗,此结论仍需更多大样本、高质量的随机对照研究进行论证。展开更多
文摘BACKGROUND Hepatitis B virus(HBV)is a major cause of hepatocellular carcinoma(HCC).HBV DNA can get integrated into the hepatocyte genome to promote carcinogenesis.However,the precise mechanism by which the integrated HBV genome promotes HCC has not been elucidated.AIM To analyze the features of HBV integration in HCC using a new reference database and integration detection method.METHODS Published data,consisting of 426 Liver tumor samples and 426 paired adjacent non-tumor samples,were re-analyzed to identify the integration sites.Genome Reference Consortium Human Build 38(GRCh38)and Telomere-to-Telomere Consortium CHM13(T2T-CHM13(v2.0))were used as the human reference genomes.In contrast,human genome 19(hg19)was used in the original study.In addition,GRIDSS VIRUSBreakend was used to detect HBV integration sites,whereas high-throughput viral integration detection(HIVID)was applied in the original study(HIVID-hg19).RESULTS A total of 5361 integration sites were detected using T2T-CHM13.In the tumor samples,integration hotspots in the cancer driver genes,such as TERT and KMT2B,were consistent with those in the original study.GRIDSS VIRUSBreakend detected integrations in more samples than by HIVID-hg19.Enrichment of integration was observed at chromosome 11q13.3,including the CCND1 pro-moter,in tumor samples.Recurrent integration sites were observed in mitochondrial genes.CONCLUSION GRIDSS VIRUSBreakend using T2T-CHM13 is accurate and sensitive in detecting HBV integration.Re-analysis provides new insights into the regions of HBV integration and their potential roles in HCC development.
文摘目的:评价补阳还五汤联合手术治疗腰椎管狭窄症的有效性。方法:应用PubMed、Embase、Web of Science、万方(WanFang)、中国知网(CNKI)、中国生物医学文献库(CBM)等数据库检索有关补阳还五汤结合手术治疗腰椎管狭窄症的文献,使用Cochrane偏倚风险评估标准对文献进行评价,应用RevMan软件进行数据分析。结果:共纳入文献10篇,涉及腰椎管狭窄症患者728例,Meta分析结果显示补阳还五汤结合手术治疗腰椎管狭窄症优于单纯手术治疗,其中有效率[OR=3.26,95%CI(1.66,6.40),P<0.05]、视觉模拟评分(VAS)[WMD=-0.61,95%CI(-1.11,-0.11),P=0.02]、Owsestry功能障碍指数(ODI)[WMD=-3.09,95%CI(-4.49,-1.70),P<0.05]、日本骨科学会腰椎疗效评分(JOA)[WMD=2.00,95%CI(0.57,3.43),P<0.05]、C反应蛋白水平[WMD=-2.24,95%CI(-2.69,-1.80),P<0.05]。结论:补阳还五汤结合手术治疗腰椎管狭窄症的疗效优于单纯手术治疗,此结论仍需更多大样本、高质量的随机对照研究进行论证。
